1-5 of 5
Vladimir Ivanov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: Phase 1b Study of Lisaftoclax (APG-2575) As a Single Agent or Combined with Other Therapeutic Agents in Patients with Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (R/R CLL/SLL)

Matthew S. Davids, Tanya Siddiqi, Asher Chanan-Khan, Alan Skarbnik, Allison M. Winter, John M. Pagel, Carrie Smith, Nashat Gabrail, Tetiana Perekhrestenko, Halyna Pylypenko, Olena Kyselova, Olena Karpenko, Tetiana Popovska, Iryna Kriachok, Hanna Usenko, Andrew Proidakov, Vladimir Ivanov, Tamila Lysa, Elena Borisenkova, Bulat Bakirov, Les Lukavetsky, Olga Uspenskaya, Tatiana S. Konstantinova, Olga S. Samoylova, Zi Chen, Bo Huang, Mingyu Li, Mohammad Ahmad, Boyd Mudenda, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2021) 138 (Supplement 1): 1554.
DOI: https://doi.org/10.1182/blood-2021-152811
Published: 2021
Journal Articles

Delays in Time to Deterioration of Health-Related Quality of Life Were Observed in Patients with Acute Myeloid Leukemia Receiving Venetoclax in Combination with Azacitidine or in Combination with Low-Dose Cytarabine

Keith W. Pratz, MD, Panayiotis Panayiotidis, MD, Christian Recher, MD PhD, Xudong Wei, PhD, Brian A Jonas, MD PhD, Pau Montesinos, MD PhD, Vladimir Ivanov, Andre C. Schuh, Courtney D. Dinardo, MDMSc, Jan Novak, Vlatko Pejsa, MD PhD, Don A. Stevens, MD, Su-Peng Yeh, MD, Inho Kim, MD PhD, Mehmet Turgut, MD, Nicola Fracchiolla, Kazuhito Yamamoto, MD PhD, Yishai Ofran, MD, Andrew H Wei, MBBS, PhD, Cat Bui, Katy Benjamin, Rajesh Kamalakar, MS, Jalaja Potluri, MD, Wellington Mendes, Jacob Devine, Walter Fiedler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–35.
DOI: https://doi.org/10.1182/blood-2020-133912
Published: 2020
Journal Articles

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Clinical Trials & Observations
Andrew H. Wei, Pau Montesinos, Vladimir Ivanov, Courtney D. DiNardo, Jan Novak, Kamel Laribi, Inho Kim, Don A. Stevens, Walter Fiedler, Maria Pagoni, Olga Samoilova, Yu Hu, Achilles Anagnostopoulos, Julie Bergeron, Jing-Zhou Hou, Vidhya Murthy, Takahiro Yamauchi, Andrew McDonald, Brenda Chyla, Sathej Gopalakrishnan, Qi Jiang, Wellington Mendes, John Hayslip, Panayiotis Panayiotidis
Journal: Blood
Blood (2020) 135 (24): 2137–2145.
DOI: https://doi.org/10.1182/blood.2020004856
Published: 2020
Includes: Supplemental data
Journal Articles

Response to Brentuximab Vedotin and Quality of Life in Patients with Relapsed/Refractory Hodgkin Lymphoma (RR HL) in the Real World Setting

Tatyana Ionova, PhD Professor, Boris Afanasiev, MD PhD Professor, Maria Andrievskih, Alim Amdiev, Elena A. Baryakh, MD PhD, Viktor Chang, Gulnara Husainova, Vladimir Ivanov, Kamil D Kaplanov, MD, Oksana Kaverina, Tatiana Klitochenko, Vyacheslav Kurakin, Olga Larionova, Darya Lazareva, Kirill Lepik, Irina Lysenko, Nataliia Mikhailova, Raisa Minullina, Oleg Mironov, Elena Misyurina, Nikita Mochkin, Tatiana Nikitina, PhD, Iurii Osipov, Tatiana Petrova, Natalia Porfirieva, Oleg Rykavitcin, Rustem Safin, Tatiana Shelekhova, Dmitrij Sherstnev, Polina Simashova, Elena Smirnova, Natalia Trenina, Evgeniy V. Vasiliev, Mikhail Volkov, Elena Volodicheva, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5296.
DOI: https://doi.org/10.1182/blood-2019-121997
Published: 2019
Journal Articles

Normal Blood and Bone Marrow Wt1 Expression Level in Extramedullary Relapse in AML Patient

Larisa Girshova, Ekaterina Romanova, Elena Gorunova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Vladimir Ivanov, Andrey Zaritskey
Journal: Blood
Blood (2012) 120 (21): 4825.
DOI: https://doi.org/10.1182/blood.V120.21.4825.4825
Published: 2012